Redefining baseline demographics: the role of genetic testing in hepatitis C virus infection.

Abstract excerpt

The current standard of care for hepatitis C virus (HCV) infection is pegylated interferon and ribavirin. Unfortunately, treatment cures at best only 40% to 50% of patients infected with genotype 1 HCV, the most common HCV genotype in Western countries. Treatment is also expensive and is often poorly tolerated. Therefore, the identification of patients most likely to benefit from treatment is clinically...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Testing
• Share to Genome-Wide Association Study
• Share to Hepacivirus